NGM313: Phase I started

NGM began a double-blind, placebo-controlled, Australian Phase I trial to evaluate single and multiple ascending

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE